FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizonal rule
CBER links to product areas
CBER links
horizonal rule

Safety Information

FDA MedWatch   |   Recalls / Withdrawals   |   FDA Patient Safety News   |   Counterfeit Initiative

2004 | 2003 | 2002 | 2001 | 2000 | 1999

horizonal rule

2004

Notification Regarding Platelets, Pheresis Collection Using the Gambro Trima Accel Automated Blood Collection System - Gambro BCT, Inc - 7/23/2004

Notice to Readers: Manufacturer's Recall of Human Rabies Vaccine - MMWR - 4/2/2004

horizonal rule

 

2003

Antibody to HBsAg ELISA Test System 3 (Ortho-Clinical Diagnostics Inc) - Increased reactive rate and false repeat reactive rate - MedWatch - 12/23/2003

Update on Particulate Matter in Blood Bags - 10/31/2003

FDA Announces Initiative to Heighten Battle Against Counterfeit Drugs - 7/16/2003

Women with Smallpox Vaccine Exposure During Pregnancy Reported to the National Smallpox Vaccine in Pregnancy Registry --- United States, 2003 - MMWR - 5/2/2003

FDA Current Thinking on Irradiating and/or Freezing Blood Components Collected and Stored in Anticoagulant/Preservative Solutions Not Specifically Approved for Such Use - 3/5/2003

Frequently Asked Questions on FDA's Continuing Investigation of Particulate Matter in Blood - 2/27/2003

Information Alert on Particulate Matter in Blood Bags - 2/7/2003

horizonal rule

 

2002

Public Health Dispatch: Investigation of Blood Transfusion Recipients with West Nile Virus Infections - MMWR - 9/13/2002

CDC Investigates Possible West Nile Virus Transmission Through Organ Transplant - Press Release - 9/1/2002

Information about West Nile Virus and Blood Safety - 8/17/2002

FDA Interim Statement Regarding Immune Globulin Intravenous (IGIV) - 8/27/2002

CDRH - Public Health Notification: Human Tissue Processed by Cryolife, Inc. - 8/21/2002 (PDF), (Text)

FDA Public Notification: PVC Devices Containing the Plasticizer DEHP - Blood bags and infusion tubing may contain DEHP-plasticized PVC - MedWatch - 7/12/2002

Important New Drug Warning - PLAS+SD (Pooled Plasma), (Human) Solvent Detergent Treated) - 3/29/2002

Immune Globulin Intravenous (Human) - Baxter Healthcare Corp - Serious thrombotic events
Post marketing reports describing serious thrombotic events (vascular occlusion) possibly associated with the administration of Immune Globulin Intravenous (Human) (IGIV). Precautionary statements, advising physicians to exercise caution in administering IGIV to patients with cardiovascular disease or previous thrombotic events, have been added to the labeling of both Baxter's Gammagard S/D and American Red Cross' Polygam S/D. The letters remind healthcare professionals of measures that may be important in reducing the risk of a thrombotic event. - MedWatch - 3/26/2002

Important Recall Information Relating to Immune Globulin Intravenous (Human) - (Bayer Corp) - 3/20/2002, Updated 3/21/2002

Lymphocyte Immune Therapy (LIT) Letter - 1/30/2002 - (Text), (PDF)
    Note: the correct CBER contact telephone number is 301-827-5102

Updated -Transfusion Related Acute Lung Injury Letter - 10/19/2001 - (Text), (PDF)

horizonal rule

 

2001

horizonal rule

 

2000

PLAS+SD (Pooled Plasma, [Human] Solvent Detergent Treated), Important Prescribing Information - MedWatch - 10/20/2000

Murex SUDS HIV-1 (Rapid EIA), Abbott Laboratories, Manufacturing problems related to the failure to meet certain panel and negative control specifications - MedWatch - 10/18/2000

FDA considers the risk of bacteremia from Red Blood Cell units using Pre-storage Leukocyte Reduction Set for Red Cells filters (Sepacell) to be very low - 9/22/2000

Autologous Cultured Chondrocytes (Carticel), Genzyme Tissue Repair - Notice of Change in Product Labeling - MedWatch - 3/16/2000

Options for Alternative Arm Preparation - Clinipad Recall - 3/9/2000 - Updated 3/28/2000

Poliovirus Vaccine Live Oral Trivalent (Orimune) - Change in storage conditions - MedWatch - 2/7/2000

Rho(D) Immune Globulin Intravenous (Human) (WinRho SDF) - Updated prescribing and treatment information: Rho(D) positive patients treated with WinRho SDF should be monitored for signs and/or symptoms of intravascular hemolysis (IVH), clinically compromising anemia, and renal insufficiency - MedWatch - 1/7/2000

horizonal rule

 

1999

Dear Doctor Letter IMPORTANT DRUG WARNING - Potential risk of ACUTE RENAL FAILURE reported to be associated with administration of Immune Globulin Intravenous (Human) - 9/24/1999 - (PDF), (Text)

Thimerosal in Vaccines: A Joint Statement of the American Academy of Pediatrics and the Public Health Service - 7/9/1999

False Negative Results With Use of Unapproved HIV Rapid Home-Use Test Kit - EZ MedTest - 7/6/1999

URGENT BIOLOGIC FIELD CORRECTION of Immune Globulin Intravenous (Human) - 7/1/1999

URGENT REQUEST for Product QUARANTINE of Immune Globulin Intravenous (Human), Alpha Therapeutic Corp. - 6/11/1999

Immune Globulin Intravenous (Human) - Associated renal adverse events - Medwatch - 6/25/1999

Albumin (Human) 25% - Medwatch - 3/5/1999

Immune Globulin Intravenous (Human) - Medwatch - 3/5/1999

 

 
horizonal rule